Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Janux Therapeutics

JANX

JANX Janux Therapeutics NASDAQ
Add to watchlist
34.78
0.00 (0.00 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    JANX Chart
    See on advanced chart >
    • Volume --
    • Turnover --
    • P/E(TTM) --
    • Turnover % --
    • P/E(Static) --
    • Market Cap --
    • P/B --
    • Shares --
    • 52 Week Range
    • Day Range

    About

    Janux Therapeutics, Inc. was incorporated under the laws of the State of Delaware on June 27, 2017. The company is an innovative biopharmaceutical company developing next-generation therapeutics based on the company's proprietary Tumor Activated T Cell...
    • Highlight
      A clinical-stage biopharmaceutical company that developing immunotherapies for cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/11/2021
    • Established Date
      06/27/2017
    • Full-time Employees
      64
    • Address
      10955 Vista Sorrento Parkway Suite 200 San Diego California 92130
    • Tel
      1-858-7514493
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App